HIF1A and ovarian cancer: Knockout of HIF-1α can redirect aerobic glycolysis in drug-resistant ovarian cancer cells to mitochondrial OXPHOS, resulting in cell death through the production of ROS, thus improving the response of cisplatin-resistant ovarian cancer cells to cisplatin.